D. E. Shaw & Co., Inc. G1 Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.2 - $4.98 $40,024 - $90,601	-18,193 Reduced 2.32%	767,066 $1.75 Million
Q1 2024 May 15, 2024	BUY	$2.1 - $4.83 $608,596 - $1.4 Million	289,808 Added 58.49%	785,259 $3.39 Million
Q4 2023 Feb 14, 2024	SELL	$1.12 - $3.73 $10,786 - $35,923	-9,631 Reduced 1.91%	495,451 $1.51 Million
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $135,933 - $297,494	-111,421 Reduced 18.07%	505,082 $727,000
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $459,685 - $586,752	186,864 Added 43.49%	616,503 $1.54 Million
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $38,724 - $122,954	-15,068 Reduced 3.39%	429,639 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $1.82 Million - $4.72 Million	349,733 Added 368.24%	444,707 $2.41 Million
Q3 2022 Nov 14, 2022	SELL	$5.17 - $16.99 $217,165 - $713,664	-42,005 Reduced 30.67%	94,974 $1.19 Million
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $553,395 - $1.17 Million	136,979 New	136,979 $677,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $307,034 - $569,184	-17,465 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $191,940 - $356,286	17,465 New	17,465 $314,000
Q2 2020 Aug 14, 2020	SELL	$9.57 - $24.37 $490,778 - $1.25 Million	-51,283 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $465,136 - $1.35 Million	51,283 New	51,283 $565,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.